Volume 238, Issue 9

Search all Psychopharmacology articles

September 2021

25 articles in this issue

Shared gray matter alterations in subtypes of addiction: a voxel-wise meta-analysis
Mengzhe Zhang
Xinyu Gao
Yong Zhang
Review 27 July 2021 Pages: 2365 - 2379
Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder
Viktor Román
Nika Adham
Béla Kiss
Original Investigation Open access 15 July 2021 Pages: 2381 - 2392
The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study
Tiffany R. Lago
Michael J. Brownstein
Christian Grillon
Original Investigation 10 May 2021 Pages: 2393 - 2403
Safety and tolerability of chronic intranasal oxytocin in older men: results from a randomized controlled trial
Jillian M. Rung
Marilyn Horta
Natalie C. Ebner
Original Investigation 12 May 2021 Pages: 2405 - 2418
Acute intranasal dopamine application counteracts the reversal learning deficit of spontaneously hypertensive rats in an attentional set-shifting task
Jay-Shake Li
Shan-Sung Yang
Claudia Mattern
Original Investigation 12 May 2021 Pages: 2419 - 2428
Reactions to reduced nicotine content cigarettes in a sample of young adult, low-frequency smokers
Maggie M. Sweitzer
Lauren R. Pacek
F. Joseph McClernon
Original Investigation 12 May 2021 Pages: 2429 - 2438
Effects of the glucocorticoid receptor antagonist PT150 on stress-induced fentanyl seeking in male and female rats
Lindsey R. Hammerslag
Emily D. Denehy
Michael T. Bardo
Original Investigation 18 May 2021 Pages: 2439 - 2447
Effect of Bifidobacterium on olanzapine-induced body weight and appetite changes in patients with psychosis
Ye Yang
Yujun Long
Jingping Zhao
Original Investigation 17 May 2021 Pages: 2449 - 2457
Reduced cortical GABA and glutamate in high schizotypy
Petya Kozhuharova
Andreea O. Diaconescu
Paul Allen
Original Investigation Open access 19 June 2021 Pages: 2459 - 2470
Anticataleptic activity of nicotine in rats: involvement of the lateral entorhinal cortex
Ilya D. Ionov
Irina I. Pushinskaya
Nicholas N. Severtsev
Original Investigation 17 May 2021 Pages: 2471 - 2483
Resveratrol attenuates arsenic-induced cognitive deficits via modulation of Estrogen-NMDAR-BDNF signalling pathway in female mouse hippocampus
Kamakshi Mehta
Kamlesh Kumar Pandey
Saroj Kaler
Original Investigation 28 May 2021 Pages: 2485 - 2502
Relative potency of intravenous oxymorphone compared to other µ opioid agonists in humans — pilot study outcomes
Shanna Babalonis
Sandra D. Comer
Sharon L. Walsh
Original Investigation 01 June 2021 Pages: 2503 - 2514
Problem-solving deficits in methcathinone use disorder
Hang-Bin Zhang
Di Zhao
Ti-Fei Yuan
Original Investigation 22 July 2021 Pages: 2515 - 2524
No evidence of the clinical utility of single-item breakpoint to inform on tobacco demand in persons with substance use disorders
Alba González-Roz
Roberto Secades-Villa
José R. Fernández-Hermida
Original Investigation 24 May 2021 Pages: 2525 - 2533
NRG1 accelerates the forgetting of fear memories and facilitates the induction of long-term depression in adult mice
Qianqian Cao
Yuan Wei
Song Lin
Original Investigation 30 June 2021 Pages: 2535 - 2542
A potential probiotic bacterium for antipsychotic-induced metabolic syndrome: mechanisms underpinning how Akkermansia muciniphila subtype improves olanzapine-induced glucose homeostasis in mice
Dongquan Huang
Jie Gao
Yongzheng Peng
Original Investigation 27 May 2021 Pages: 2543 - 2553
Low doses of ketamine and guanosine abrogate corticosterone-induced anxiety-related behavior, but not disturbances in the hippocampal NLRP3 inflammasome pathway
Anderson Camargo
Ana Paula Dalmagro
Ana Lúcia S. Rodrigues
Original Investigation 03 August 2021 Pages: 2555 - 2568
Haloperidol rescues the schizophrenia-like phenotype in adulthood after rotenone administration in neonatal rats
Thiago Garcia Varga
Juan Guilherme de Toledo Simões
Tatiana Rosado Rosenstock
Original Investigation 05 June 2021 Pages: 2569 - 2585
The GABA_B receptor positive allosteric modulator ASP8062 reduces operant alcohol self-administration in male and female Sprague Dawley rats
Colin N. Haile
Benjamin A. Carper
Therese A. Kosten
Original Investigation 06 July 2021 Pages: 2587 - 2600
Adaptive aspects of impulsivity and interactions with effects of catecholaminergic agents in the 5-choice serial reaction time task: implications for ADHD
Chiara Toschi
Mona El-Sayed Hervig
Trevor W. Robbins
Original Investigation Open access 09 June 2021 Pages: 2601 - 2615
Memory enhancing effects of nicotine, cocaine, and their conditioned stimuli; effects of beta-adrenergic and dopamine D2 receptor antagonists
Michael Wolter
Thomas Lapointe
Francesco Leri
Original Investigation 26 June 2021 Pages: 2617 - 2628
Evidence accumulation and associated error-related brain activity as computationally-informed prospective predictors of substance use in emerging adulthood
Alexander S. Weigard
Sarah J. Brislin
Mary M. Heitzeg
Original Investigation 25 June 2021 Pages: 2629 - 2644
Sign tracking predicts suboptimal behavior in a rodent gambling task
Megan Swintosky
James T. Brennan
Sara E. Morrison
Original Investigation 30 June 2021 Pages: 2645 - 2660
Comment on Pohorala et al.: Sign-tracking as a predictor of addiction vulnerability
Shelly B. Flagel
Terry E. Robinson
Martin Sarter
Letter to the Editor 26 July 2021 Pages: 2661 - 2664
Comment on Flagel et al.: Sign-tracking as a predictor of addiction vulnerability
Veronika Pohořalá
Thomas Enkel
Rick E. Bernardi
Letter to the Editor Open access 29 July 2021 Pages: 2665 - 2666

Volume 238, Issue 9

Shared gray matter alterations in subtypes of addiction: a voxel-wise meta-analysis

Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder

The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study

Safety and tolerability of chronic intranasal oxytocin in older men: results from a randomized controlled trial

Acute intranasal dopamine application counteracts the reversal learning deficit of spontaneously hypertensive rats in an attentional set-shifting task

Reactions to reduced nicotine content cigarettes in a sample of young adult, low-frequency smokers

Effects of the glucocorticoid receptor antagonist PT150 on stress-induced fentanyl seeking in male and female rats

Effect of Bifidobacterium on olanzapine-induced body weight and appetite changes in patients with psychosis

Reduced cortical GABA and glutamate in high schizotypy

Anticataleptic activity of nicotine in rats: involvement of the lateral entorhinal cortex

Resveratrol attenuates arsenic-induced cognitive deficits via modulation of Estrogen-NMDAR-BDNF signalling pathway in female mouse hippocampus

Relative potency of intravenous oxymorphone compared to other µ opioid agonists in humans — pilot study outcomes

Problem-solving deficits in methcathinone use disorder

No evidence of the clinical utility of single-item breakpoint to inform on tobacco demand in persons with substance use disorders

NRG1 accelerates the forgetting of fear memories and facilitates the induction of long-term depression in adult mice

A potential probiotic bacterium for antipsychotic-induced metabolic syndrome: mechanisms underpinning how Akkermansia muciniphila subtype improves olanzapine-induced glucose homeostasis in mice

Low doses of ketamine and guanosine abrogate corticosterone-induced anxiety-related behavior, but not disturbances in the hippocampal NLRP3 inflammasome pathway

Haloperidol rescues the schizophrenia-like phenotype in adulthood after rotenone administration in neonatal rats

The GABA_B receptor positive allosteric modulator ASP8062 reduces operant alcohol self-administration in male and female Sprague Dawley rats

Adaptive aspects of impulsivity and interactions with effects of catecholaminergic agents in the 5-choice serial reaction time task: implications for ADHD

Memory enhancing effects of nicotine, cocaine, and their conditioned stimuli; effects of beta-adrenergic and dopamine D2 receptor antagonists

Evidence accumulation and associated error-related brain activity as computationally-informed prospective predictors of substance use in emerging adulthood

Sign tracking predicts suboptimal behavior in a rodent gambling task

Comment on Pohorala et al.: Sign-tracking as a predictor of addiction vulnerability

Comment on Flagel et al.: Sign-tracking as a predictor of addiction vulnerability

Navigation